+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Overactive Bladder Drug"

Overactive Bladder Treatment Global Market Report 2024 - Product Thumbnail Image

Overactive Bladder Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Overactive Bladder (OAB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Overactive Bladder (OAB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Overactive Bladder - Pipeline Insight, 2021 - Product Thumbnail Image

Overactive Bladder - Pipeline Insight, 2021

  • Drug Pipelines
  • July 2021
  • 60 Pages
  • Global
From
From
From
From
From
From
Global Overactive Bladder Therapeutics Market 2020-2024 - Product Thumbnail Image

Global Overactive Bladder Therapeutics Market 2020-2024

  • Report
  • August 2020
  • 120 Pages
  • Global
From
Loading Indicator

The Overactive Bladder Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat overactive bladder, a condition characterized by frequent urination, urgency, and incontinence. These drugs work by relaxing the bladder muscles, reducing the urge to urinate, and improving bladder control. Commonly used drugs include anticholinergics, beta-3 agonists, and muscarinic receptor antagonists. These drugs are available in both oral and topical formulations. The Overactive Bladder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Astellas Pharma, Allergan, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more